NHERF1/EBP50 Is a New Marker in Colorectal Cancer
Human colorectal cancer (CRC) arises from activating mutations in the Wnt/β-catenin pathway that converge with additional molecular changes to shape tumor development and patient prognosis. We report here that Na+/H+ exchanger 3 regulating factor 1 (NHERF1)/EBP50, an adaptor molecule that interacts...
Main Authors: | Yuho Hayashi, Jennifer R. Molina, Stanley R. Hamilton, Maria-Magdalena Georgescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-12-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800193 |
Similar Items
-
NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells
by: Atsushi Kawase, et al.
Published: (2021-03-01) -
HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers
by: Lucija Lulić, et al.
Published: (2023-08-01) -
Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation
by: Jennifer R. Molina, et al.
Published: (2010-06-01) -
Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients
by: Laura Schirosi, et al.
Published: (2020-02-01) -
EBP50 Depletion and Nuclear β-Catenin Accumulation Engender Aggressive Behavior of Colorectal Carcinoma through Induction of Tumor Budding
by: Takashi Itou, et al.
Published: (2023-12-01)